Careers  |  Sign In  |  Register

Latest in Pathology & Lab Medicine

Reuters Health • The Doctor's Channel Daily Newscast

Chemotherapy sensitivity/resistance testing not ready for prime time

NEW YORK (Reuters Health) – No chemotherapy sensitivity and resistance assays have sufficient supporting evidence to justify their use in oncology practice. That’s the conclusion of an American Society of Clinical Oncology (ASCO) panel, reporting in the Journal of Clinical Oncology online July...

Reuters Health • The Doctor's Channel Daily Newscast

Occult lymph node metastasis does not impact breast cancer survival

NEW YORK (Reuters Health) – In women undergoing breast-conserving therapy for early breast cancer, the presence of occult metastasis not seen with routine pathological examination in sentinel lymph nodes (SLNs) is not associated with poorer survival. However, the presence of occult bone marrow metastasis...

Reuters Health • The Doctor's Channel Daily Newscast

BAL-directed therapy no benefit for children with CF

NEW YORK (Reuters Health) – In infants and young children with cystic fibrosis, treating Pseudomonas aeruginosa infection based on bronchoalveolar lavage (BAL) rather than oropharyngeal cultures does not improve outcomes, according to an Australasian study. “BAL-directed therapy did not reduce...